Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Zoetis (NY: ZTS )

165.89 -3.48 (-2.05%)
Official Closing Price Updated: 7:00 PM EST, Jan 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Zoetis

< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever
These companies lead their respective markets, making them must-haves for buy-and-hold dividend investors. 
Via The Motley Fool
How Is The Market Feeling About Zoetis?
Via Benzinga
Here's How Much You Would Have Made Owning Zoetis Stock In The Last 10 Years
Via Benzinga
Big Biopharma Trails Behind The Market: JP Morgan's 2025 Outlook on Eli Lilly, Merck, and More
JP Morgan highlights 2025 growth prospects for biopharma, animal health, and specialty pharma stocks. Key picks include Eli Lilly, Zoetis, and Bristol-Myers Squibb. 
Via Benzinga
5 Magnificent Dividend Growth Stocks Down 24% to 41% to Buy Before 2025 for a Lifetime of Passive Income
Via The Motley Fool
$100 Invested In This Stock 10 Years Ago Would Be Worth This Much Today
Via Benzinga
If You Invested $1000 In This Stock 10 Years Ago, You Would Have $4,400 Today
Via Benzinga
Here's How Much $1000 Invested In Zoetis 10 Years Ago Would Be Worth Today
Via Benzinga
A Once-in-a-Decade Opportunity: 2 Magnificent S&P 500 Stocks Down 37% and 28% to Buy Before 2025
Via The Motley Fool
Topics Stocks
Exposures US Equities
This Autodesk Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Via Benzinga
1 Magnificent S&P 500 Dividend Stock Down 12% to Buy After Its Recent Pullback
Zoetis looks like a classic example of a premium business trading at a fair price following its recent dip. 
Via The Motley Fool
Topics Stocks
Exposures US Equities
Wall Street Rallies On Election Day, Palantir Skyrockets, Bitcoin Tops $70,000: What's Driving Markets Tuesday?
Wall Street rallied on Tuesday as improved investor sentiment aligned with millions of Americans casting their votes for the 47th president. 
Via Benzinga
In-Depth Examination Of 7 Analyst Recommendations For Zoetis
Via Benzinga
$1000 Invested In Zoetis 10 Years Ago Would Be Worth This Much Today
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Wall Street Struggles Ahead Of Election Day, Energy Sector Outperforms, Solar Stocks Rise: What's Driving Markets Monday?
The U.S. stock market struggled to gain momentum on Monday as investors remained cautious ahead of Election Day on Tuesday. 
Via Benzinga
Zoetis Q3 Earnings Beat, Companion Animal Segment Growth Gives Confidence Into 2025: Analyst
Zoetis Inc's Q3 2024 results show a 16% EPS increase and an 11% revenue boost. The company raises its 2024 guidance, highlighting strong global growth in key segments. 
Via Benzinga
Topics Earnings
Exposures Financial
Where Zoetis Stands With Analysts
Via Benzinga
Here's How Much You Would Have Made Owning Zoetis Stock In The Last 10 Years
Via Benzinga
Here's How Much $100 Invested In Zoetis 10 Years Ago Would Be Worth Today
Via Benzinga
How Is The Market Feeling About Zoetis?
Via Benzinga
Zoetis (ZTS) Q3 2024 Earnings Call Transcript
ZTS earnings call for the period ending September 30, 2024. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Zoetis Barks Up A Third-Quarter Beat And Raise, But Stock Slips
Zoetis stock inched higher Monday after the animal health company beat third-quarter expectations and raised its outlook. 
Via Investor's Business Daily
'Venture Investing Is Random,' Says Kevin O'Leary. The Craziest Bets, Like Cat DNA Tests, Often Cover All The Losses
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Elanco's Dermatology Treatment Secures FDA Approval For Itchy Dogs, Analyst Highlights Label Warnings And Efficacy
FDA approves Elanco's once-daily oral treatment, Zenrelia, for controlling itching in dogs with allergic and atopic dermatitis. The drug, proven effective in studies, faces adoption challenges due to... 
Via Benzinga
Exposures Product Safety
The Latest Analyst Ratings For Zoetis
Via Benzinga
Here's How Much $100 Invested In Zoetis 10 Years Ago Would Be Worth Today
Via Benzinga
Starbucks To Rally More Than 22%? Here Are 10 Top Analyst Forecasts For Wednesday
Via Benzinga
Jim Cramer Says This Retailer Yields 3%: 'Which Is Quite Good'
Jim Cramer discusses PROCEPT BioRobotics, Zoetis, Target and Consolidated Edison. " 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.